Preliminary Final Report
Filed with ASX · · 239 pages · English
N/A (Translation of Registrant’s name into English) AUSTRALIA (Jurisdiction of incorporation or organization) Level 38, 55 Collins Street Melbourne, VIC, 3000, Australia Telephone: +61 (3) 9639 6036 (Address of principal executive offices) Silviu Itescu Chief Executive Officer Telephone: +61 (3) 9639 6036; Fax: +61 (3) 9639 6030 Level 38, 55 Collins Street Melbourne, VIC, 3000, Australia (Name, Te
In the deck
Earlier from Mesoblast
- US$45 Million Private Placement to Major Shareholders
- Reinstatement to Quotation
- Rexlemestrocel-L Improves LVEF, Preceding Reduction in MACE
- Third Quarter Results Presentation
- MSB Q3 Financial Results and Operational Highlights
Later from Mesoblast
- MSB Annual Financial Results and Operational Highlights
- Submits New Information to FDA IND File for SR-aGVHD
- First Quarter Financial Results on Form 6-K
- MSB Q1 Financial Results and Operational Highlights
- Long-Term Survival for Acute GvHD Treatment with Remestemcel
Follow Mesoblast into a list and get an email when it puts out news.
Follow Mesoblast